Weight Loss
US$ 26.34
new glp-1 medications What to Make of the Coverage and Cost Landscape MCT2D | The Benefits of
Description
These agents produce clinically meaningful weight loss primarily through sustained appetite suppression and reduced energy intake
As part of a 2021 clinical trial published in JAMA , 741 people received weekly semaglutide injections, adjusted their diets and exercised for 20 weeks
"Semaglutide and Renal Outcomes in Type 2 Diabetes." NEJM, 2022
GLP-1 medication paired with exercise produced the greatest total weight loss while also preserving bone density
The licensed U.S
Its Phase 3 data show double-digit weight-loss, deep HbA 1c cuts, and promising cardiometabolic markersall while regulators on two continents fast-track review
